An experimental vaccine aimed at preventing the return of glioblastoma, one of the deadliest types of brain cancer, shows promise in patients 65 and under, according to clinical trial results. ↧ Experimental vaccine shows promise against deadly brain cancer in s... The vaccine, called SurVaxM, aims to prevent the recurrence of glioblastoma, an aggressive brain cancer with few major advances in treatment.
published
An experimental vaccine aimed at preventing the return of glioblastoma, one of the deadliest types of brain cancer, shows promise in patients 65 and under, according to clinical trial results.
Open the original public source →
Latest documented BWB result
See Billy's timestamped results and follow-through.
Review the latest gains posts, original timestamps, and proof images published by Banking With Billy.
Historical results are not a promise of future performance. Trading involves substantial risk.This public post is a timestamped information archive, not personalized financial advice. Alerts can change as markets move. Join Billy's private group for the complete daily stream and follow-through.